The effect of anthocyanins on obesity-related disease in obese adults with hyperlipidemia

The study on anti-atherosclerosis effects and molecular mechanisms of anthocyanins

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-08000240

Enrollment

Unknown

Registered

2008-12-10

Start date

2008-11-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

obesity and obesity-related disease

Interventions

Group A:placebo capsule, other measures follow the interventional group

Group B:Medox capsule, twice a day for 6 months, half an hour after meal to take capsules

Eligibility

Sex/Gender

All

Age

30 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Body Mass Index (BMI)>=28.0 kg/m2, or male's waist>=85cm, female's waist>=80cm; 2. Total cholesterol (TC)>=5.72mmol/L.

Exclusion criteria

Exclusion criteria: 1. Obvious weight change in the past three months; 2. History of obesity with known cause; 3. Patients with a history of diabetes, an acute myocardial infarction and a stroke; 4. History or evidence of clinically significant liver disease, kidney disease, cancer or uncontrolled thyroid disease; 5. Recent use (within six months) of medications for regulating the level of lipid or blood glucose; 6. Pregnant or breast-feeding woman.

Design outcomes

Primary

Measure	Time frame
adipose secreting factors, insulin, level of lipids;	—

Secondary

Measure	Time frame
inflammatory factors, platelet aggregation;	—

Countries

China

Contacts

Public ContactLing Wenhua

lingwh@mail.sysu.edu.cn+86 020 87331597

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 11, 2026